UNSPSC 51285307: Nitrofurantoin

This classification denotes a urinary anti-infective agent with the molecular formula C8H6N4O5, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 927AH8112L, chemically known as hydantoin, 1-(5-nitro-furfurylideneamino)- but more generally known as nitrofurantoin, which bears U.S. National Institutes of Health Compound Identifier 4509. The European Medicines Agency schedules Nitrofurantoin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09326MIG.

UNSPSC 51285307 Nitrofurantoin is a Commodity code, but the recent state and local opportunities posted under it do not align with nitrofurantoin procurement — the code shows little relevant recent activity. The four posted solicitations instead reflect miscoded or tangentially related pharmaceutical and medical supply acquisitions: naloxone and drug deactivation systems from Seminole County, Florida; a Texas HHS therapeutic pharmacy initiative research request; Tampa Fire Department medical and first aid supplies; and a Minnesota multistate cooperative pharmaceutical and OTC product agreement. None of these opportunities target nitrofurantoin specifically, and the mismatch between the code's nominal scope and the actual work being solicited suggests either systematic miscoding at issuing agencies or the code's use as a catch-all for broader pharmacy and medical procurement activity.

When opportunities do post under this code, they come from state health and human services agencies, county public health departments, cities procuring for emergency services, and multistate cooperative purchasing organizations. Geographic activity spans Florida, Texas, Minnesota, and Oregon across the recent record. The issuing-body mix reflects healthcare infrastructure — public health departments, fire rescue divisions, and state pharmacy benefit programs — rather than focused procurement of a single pharmaceutical product. Businesses tracking this code should monitor whether future solicitations narrow to actual nitrofurantoin supply contracts or continue to use the code for general pharmacy procurement; the current record offers no actionable signal for vendors seeking to bid on nitrofurantoin products specifically.